<?xml version="1.0" encoding="UTF-8"?>
<p>Diabetic rats treated with either the DBT34 microbial extract or the drug sitagliptin exhibited significant (
 <italic>p</italic> â‰¤ 0.001) reductions in total cholesterol, LDL-cholesterol, and VLDL-cholesterol in comparison to rats serving as the vehicle control and diabetic control. In contrast, HDL-cholesterol levels were not significantly altered (
 <xref ref-type="fig" rid="ijms-21-07364-f007">Figure 7</xref>).
</p>
